BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17885368)

  • 1. Diagnostic trinity: Graves' disease on F-18 FDG PET.
    Chen YK; Wang YF; Chiu JS
    Clin Nucl Med; 2007 Oct; 32(10):816-7. PubMed ID: 17885368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated 18F-FDG uptake in skeletal muscles and thymus: a clue for the diagnosis of Graves' disease.
    Chen YK; Chen YL; Liao AC; Shen YY; Kao CH
    Nucl Med Commun; 2004 Feb; 25(2):115-21. PubMed ID: 15154698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of FDG uptake in bilateral thyroid glands.
    Chen YK; Chen YL; Cheng RH; Yeh CL; Lee CC; Hsu CH
    Nucl Med Commun; 2007 Feb; 28(2):117-22. PubMed ID: 17198352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [F-qi-FDG PET of the thyroid gland in Graves' disease].
    Börner AR; Voth E; Wienhard K; Wagner R; Schicha H
    Nuklearmedizin; 1998; 37(7):227-33. PubMed ID: 9830612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT imaging of atypical subacute thyroiditis in thyrotoxicosis: A case report.
    Yoshida K; Yokoh H; Toriihara A; Fujii H; Harata N; Isogai J; Tateishi U
    Medicine (Baltimore); 2017 Jul; 96(30):e7535. PubMed ID: 28746199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography.
    Boerner AR; Voth E; Theissen P; Wienhard K; Wagner R; Schicha H
    Thyroid; 1998 Sep; 8(9):765-72. PubMed ID: 9777746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma.
    Broski SM; Bou-Assaly W; Gross MD; Fig LM
    Clin Nucl Med; 2009 Apr; 34(4):251-3. PubMed ID: 19300063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated F-18 FDG uptake in the thymus in Graves' disease.
    Chen YK; Chen YL
    Clin Nucl Med; 2003 Feb; 28(2):142-3. PubMed ID: 12544139
    [No Abstract]   [Full Text] [Related]  

  • 9. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
    Uslu-Beşli L; Kabasakal L; Sağer S; Cicik E; Asa S; Sönmezoğlu K
    Nucl Med Commun; 2017 Nov; 38(11):964-970. PubMed ID: 28863123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography.
    Liu Y
    Ann Nucl Med; 2009 Jan; 23(1):17-23. PubMed ID: 19205834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
    Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
    Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
    El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hashimoto thyroiditis and Takayasu aortitis: visualization of the thyroid gland and ring appearance of the mediastinum on F-18-FDG PET.
    Shih G; Shih WJ; Huang WS; Milan PP
    Clin Nucl Med; 2008 May; 33(5):377-9. PubMed ID: 18431164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 FDG PET/CT study showing cervical extension of thymic tissue.
    Wong KK; Foster E; Piert M
    Clin Nucl Med; 2008 Aug; 33(8):547-8. PubMed ID: 18645374
    [No Abstract]   [Full Text] [Related]  

  • 15. The frequency and spectrum of thymus 2-[fluorine-18] fluoro-2-deoxy-D-glucose uptake patterns in hyperthyroidism patients.
    Chen YK; Yeh CL; Chen YL; Wang SC; Cheng RH; Kao PF
    Acad Radiol; 2011 Oct; 18(10):1292-7. PubMed ID: 21893295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treadmill exercise inducing mild to moderate ischemia has no significant effect on skeletal muscle or cardiac 18F-FDG uptake and image quality on subsequent whole-body PET scan.
    Lyall A; Capobianco J; Strauss HW; Gonen M; Schöder H
    J Nucl Med; 2012 Jun; 53(6):917-21. PubMed ID: 22586146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of thymic uptake at 18F-FDG PET.
    Ferdinand B; Gupta P; Kramer EL
    Radiographics; 2004; 24(6):1611-6. PubMed ID: 15537971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
    Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
    Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer.
    Alzahrani AS; Abouzied ME; Salam SA; Mohamed G; Rifai A; Al Sugair A; Amin T
    Eur J Endocrinol; 2008 May; 158(5):683-9. PubMed ID: 18426827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.